As reported in the Journal of Clinical Oncology by Yamamoto et al, the final overall survival analysis of the Japanese phase III PRECIOUS study showed a significant benefit with the addition of pertuz…
SIGX1094 received fast track designation from the FDA for diffuse gastric cancer.
Oncogene – Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
The Ministry of Health, Labour, and Welfare in Japan has approved epcoritamab for relapsed or refractory follicular lymphoma.
Melvin Chua: The beauty of academic medicine in global oncology collaboration / academic medicine, cancer, Head and Neck Cancer, Melvin Chua, NPC patients,
Cancer Medicine is an open access, broad-scope oncology journal covering clinical cancer research, cancer biology, cancer prevention, & bioinformatics.
In this issue of Cancer Cell, Palmer et al. describe the discovery and preclinical testing of the first-in-class CDK4-selective inhibitor atirmociclib. By sparing CDK6, atirmociclib has…
Tambiciclib plus zanubrutinib generated responses in patients with relapsed/refractory diffuse large B-cell lymphoma.
